We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where BridgeBio Pharma, Inc. (NASDAQ:BBIO) stands against ...

The company has debuted its newest venture—GondolaBio, a biopharma startup. It will focus on developing therapies for genetic and rare diseases. Overall BBIO ranks 12th on our list of the best ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...

In recent years, the scale of biopharma investment into Ireland has accelerated, with some significant investments being made by the biggest companies in the industry. The country has always been ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...

Europe to review safety data for Eisai-Biogen Alzheimer's drug Healthcare & Pharmaceuticalscategory· January 31, 2025 Indian biopharma company Biocon reported third-quarter revenue on Thursday ...

India's pharmaceutical sector is witnessing remarkable growth, almost achieving its export target before FY25. Drug formulations and biologicals lead the exports, supported by significant growth in ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Companies that have grown profits and net profit margins over the past 12 months ...